ACTIMMUNE^® has a well-established, predictable safety profile in both chronic granulomatous disease (CGD) and severe, malignant osteopetrosis.

The most common adverse events observed in patients with CGD were flu-like symptoms (e.g., headache, fatigue, fever, myalgia, and rigors). Similar adverse events were observed in patients with severe malignant osteopetrosis. Click on the links below for more complete safety information.

• Click here for common adverse events
• Click here for contraindications
• Click here for safety warnings

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of patients.

For U.S. resident use only. The product discussed herein may have different product labeling in different countries. Please see the full U.S. Prescribing Information (pdf file).